NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY

Clinical trials for NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY explained in plain language.

Never miss a new study

Get alerted when new NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY trials appear

Sign up with your email to follow new studies for NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New nasal spray aims to rescue vision after sudden eye attack

Disease control Not yet recruiting

This study is testing whether a nasal spray containing a nerve growth factor protein (cenegermin) can help improve vision in adults who recently experienced sudden vision loss from NAION. About 272 participants will be randomly assigned to receive either the active spray or a pla…

Matched conditions: NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY

Phase: PHASE3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY

Get alerted when new NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY trials appear

New nasal spray aims to rescue vision after sudden eye attack